Average Co-Inventor Count = 2.40
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Aradigm Corporation (13 from 130 patents)
2. Oregon State University (2 from 313 patents)
3. Grifols, S.a. (2 from 50 patents)
4. Blanchard, James (0 patent)
15 patents:
1. 11116765 - Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria
2. 11026941 - Concentrated, inhalable ciprofloxacin formulation
3. 10420765 - Concentrated, inhalable ciprofloxacin formulation
4. 10376508 - Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria
5. 9844548 - Liposomal ciprofloxacin formulations with encapsulated ciprofloxacin nanocrystals
6. 9545401 - Concentrated, inhalable ciprofloxacin formulation
7. 9532986 - Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria
8. 9259424 - Concentrated, inhalable antibiotic formulation
9. 9078897 - Concentrated, inhalable antibiotic formulation
10. 9028864 - Concentrated, inhalable antibiotic formulation
11. 8414915 - Dual action, inhaled formulations providing both an immediate and sustained release profile
12. 8268347 - Dual action, inhaled formulations providing both an immediate and sustained release profile
13. 8119156 - Dual action, inhaled formulations providing both an immediate and sustained release profile
14. 8071127 - Dual action, inhaled formulations providing both an immediate and sustained release profile
15. 7258850 - Methods and compositions for treating erectile dysfunction